These data taken together suggest that MPA acting through PRA/PRB increased RANKL expression in the postmenopausal breast and that RANKL-induced proliferation and influence on mammary stem cells may contribute to hormone-dependent tumor formation in the postmenopausal breast. Here, TNFSF11 is linked to neoplasm.